PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
This Quarter Return
+22.05%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$19B
AUM Growth
+$19B
(+17%)
Cap. Flow
+$591M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
36.62%
Holding
320
New
37
Increased
84
Reduced
103
Closed
35
Top Buys
| 1 |
Indivior
INDV
|
$783M |
| 2 |
Meta Platforms (Facebook)
META
|
$233M |
| 3 |
Cloudflare
NET
|
$176M |
| 4 |
Broadcom
AVGO
|
$117M |
| 5 |
Applied Materials
AMAT
|
$107M |
Top Sells
| 1 |
Ferguson
FERG
|
$398M |
| 2 |
Apple
AAPL
|
$255M |
| 3 |
NVIDIA
NVDA
|
$103M |
| 4 |
Rambus
RMBS
|
$103M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$103M |
Sector Composition
| 1 | Technology | 39.86% |
| 2 | Healthcare | 20.98% |
| 3 | Financials | 13.97% |
| 4 | Industrials | 10.12% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Interactive Brokers
IBKR
$28.5B
| $39.6M | 0.21% |
354,480
+117,196
| +49% | +$13.1M |
|
102
RLI Corp
RLI
$6.17B
| $38.6M | 0.2% |
260,000
| – | – |
|
103
Integer Holdings
ITGR
$3.71B
| $38.3M | 0.2% |
+328,668
| New | +$38.3M |
|
104
Intercontinental Exchange
ICE
$100B
| $35.6M | 0.19% |
259,162
+2,860
| +1% | +$393K |
|
105
Globant
GLOB
$2.82B
| $35.3M | 0.19% |
174,876
+6,368
| +4% | +$1.29M |
|
106
Alnylam Pharmaceuticals
ALNY
$58.6B
| $35.1M | 0.18% |
235,000
+50,000
| +27% | +$7.47M |
|
107
Trupanion
TRUP
$1.9B
| $34.5M | 0.18% |
1,250,000
| – | – |
|
108
DexCom
DXCM
$30.9B
| $33.7M | 0.18% |
243,000
-1,667
| -0.7% | -$231K |
|
109
Madrigal Pharmaceuticals
MDGL
$9.7B
| $33.4M | 0.18% |
+125,205
| New | +$33.4M |
|
110
Icon
ICLR
$14B
| $32.6M | 0.17% |
97,090
+46,574
| +92% | +$15.6M |
|
111
Immunocore
IMCR
$1.78B
| $32.6M | 0.17% |
501,300
| – | – |
|
112
Becton Dickinson
BDX
$54.3B
| $32.2M | 0.17% |
130,177
+68,673
| +112% | +$17M |
|
113
CG Oncology
CGON
$2.19B
| $32M | 0.17% |
+729,166
| New | +$32M |
|
114
Linde
LIN
$221B
| $31.3M | 0.16% |
67,405
-18,912
| -22% | -$8.78M |
|
115
Merit Medical Systems
MMSI
$5.34B
| $31.3M | 0.16% |
412,765
-65,577
| -14% | -$4.97M |
|
116
Brown & Brown
BRO
$31.4B
| $30.6M | 0.16% |
+350,000
| New | +$30.6M |
|
117
Pliant Therapeutics
PLRX
$105M
| $30M | 0.16% |
2,015,000
| – | – |
|
118
Y-mAbs Therapeutics
YMAB
$390M
| $29.8M | 0.16% |
1,831,000
-225,872
| -11% | -$3.67M |
|
119
NewAmsterdam Pharma
NAMS
$2.8B
| $29.6M | 0.16% |
+1,252,586
| New | +$29.6M |
|
120
Vera Therapeutics
VERA
$1.47B
| $29.1M | 0.15% |
675,000
-50,000
| -7% | -$2.16M |
|
|
LBPH
121
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $28.2M | 0.15% |
1,305,431
+305,431
| +31% | +$6.6M |
|
122
Analog Devices
ADI
$120B
| $28.1M | 0.15% |
142,042
-12,388
| -8% | -$2.45M |
|
123
Establishment Labs
ESTA
$1.11B
| $27.8M | 0.15% |
546,519
+320,000
| +141% | +$16.3M |
|
124
ProAssurance
PRA
$1.22B
| $27.8M | 0.15% |
2,162,500
| – | – |
|
125
Insulet
PODD
$24.2B
| $27.8M | 0.15% |
161,943
+50,972
| +46% | +$8.74M |
|